← Home
🚀 Sign up Free for Company Insights & Valuation!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free
Novozymes 
Healthcare & biotech / Biotechnology
At a Glance | Core Facts | Company Due Diligence | Industry Due Diligence | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebBalance Sheet
Pay attention and research significant changes from year to year values. [ ! ]
| Fixed Column | Cash And Cash Equivalents | Short Term Investments | Cash And Short Term Investments | Net Receivables | Inventory | Other Current Assets | Total Current Assets | Property Plant Equipment Net | Goodwill | Intangible Assets | Goodwill And Intangible Assets | Long Term Investments | Tax Assets | Other Non Current Assets | Total Non Current Assets | Other Assets | Total Assets | Account Payables | Short Term Debt | Tax Payables | Deferred Revenue | Other Current Liabilities | Total Current Liabilities | Long Term Debt | Deferred Revenue Non Current | Deferred Tax Liabilities Non Current | Other Non Current Liabilities | Total Non Current Liabilities | Other Liabilities | Capital Lease Obligations | Total Liabilities | Preferred Stock | Common Stock | Retained Earnings | Accumulated Other Comprehensive Income Loss | Other Total Stockholders Equity | Total Stockholders Equity | Total Equity | Total Liabilities And Stockholders Equity | Minority Interest | Total Liabilities And Total Equity | Total Investments | Total Debt | Net Debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12 | 280.0 | 4.0 | 284.0 | 0.0 | 720.6 | 874.8 | 1879.4 | 2968.3 | 5605.0 | 4419.2 | 10024.2 | 38.7 | 275.0 | 10.0 | 13316.2 | 0.0 | 15195.6 | 423.1 | 266.39 | 60.9 | 0.0 | 337.9 | 1088.3 | 1530.4 | 105.3 | 1255.9 | 39.7 | 2931.3 | 0.0 | 0.0 | 4019.6 | 0.0 | 125.6 | 11032.4 | 0.0 | 18.0 | 11176.0 | 11176.0 | 15195.6 | 0.0 | 15195.6 | 42.7 | 1796.8 | 1516.8 |
| 2023-12 | 1116.0 | 40.0 | 1156.0 | 3772.0 | 3627.0 | 907.0 | 9462.0 | 12325.0 | 1975.0 | 2557.0 | 4532.0 | 227.0 | -22.0 | 1845.0 | 18929.0 | 0.0 | 28391.0 | 1616.0 | 3173.0 | 24.57 | 0.0 | 2448.42 | 7262.0 | 4359.16 | 0.0 | 0.0 | 2418.83 | 6778.0 | 0.0 | 168.16 | 14040.0 | 0.0 | 562.0 | 13755.0 | 0.0 | -339.0 | 13978.0 | 14028.09 | 28391.0 | 50.09 | 28391.0 | 267.0 | 7733.0 | 6617.0 |
| 2022-12 | 1041.0 | 80.0 | 1121.0 | 3605.0 | 3803.0 | 792.0 | 9241.0 | 12074.0 | 2007.0 | 2691.0 | 4698.0 | 235.0 | 1623.0 | 112.0 | 18742.0 | 0.0 | 27983.0 | 1869.0 | 3042.0 | 326.0 | 138.0 | 1726.0 | 6963.0 | 3907.0 | 129.0 | 1653.0 | 2885.0 | 6792.0 | 0.0 | 411.0 | 13755.0 | 0.0 | 562.0 | 13062.0 | 213.0 | 0.0 | 13837.0 | 14228.0 | 27983.0 | 391.0 | 27983.0 | 315.0 | 411.0 | -630.0 |
| 2021-12 | 963.0 | 75.0 | 1038.0 | 2988.0 | 2992.0 | 880.0 | 7823.0 | 10185.0 | 2020.0 | 3004.0 | 5024.0 | -16.0 | 1637.0 | 114.0 | 16944.0 | 0.0 | 24767.0 | 1490.0 | 2098.0 | 486.0 | 163.0 | 3412.0 | 5673.0 | 360.0 | 98.0 | 1337.0 | 6528.0 | 6888.0 | 0.0 | 482.0 | 12561.0 | 40.0 | 564.0 | 11303.0 | -40.0 | -80.0 | 11827.0 | 12206.0 | 24767.0 | 379.0 | 24767.0 | 59.0 | 482.0 | -481.0 |
Wait! There's more — sign up for free or log in